Bilcare Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve the Un-Audited Financial Results For ....
BI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bilcare Limited has informed the BSE that a meeting of its Board of Directors is scheduled for Thursday, 12 February 2026. The Board will consider and approve the Unaudited Financial Results (both Standalone and Consolidated) for the quarter and nine months ended 31 December 2025. The trading window for dealing in the company's securities remains closed from 1 January 2026 until 48 hours after the results are declared (up to 14 February 2026), in line with SEBI insider trading norms. This is a standard regulatory intimation under SEBI LODR Regulations 29(1) and 33, with no actual financial figures disclosed in this notice.
No direct impact on shareholders or the stock price; this is a routine pre-results announcement. Investors should watch for the actual Q3 FY26 results on 12 February 2026 for any meaningful performance signals.